[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Drug Eluting Balloon for Peripheral Artery Disease Market Growth 2023-2029

February 2023 | 98 pages | ID: G37279C07F3EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

A drug eluting balloon is a semi-compliant angioplasty balloon that is surrounded by an anti-proliferative medicine. The medicine is ejected to the vessel wall during the inflation of the balloon. The active substance of the balloon is highly lipophilic (dissolved in lipids or fats). The drug eluting balloon homogeneously delivers the drug to the vessel and provides treatment for peripheral artery disease.

LPI (LP Information)' newest research report, the “Drug Eluting Balloon for Peripheral Artery Disease Industry Forecast” looks at past sales and reviews total world Drug Eluting Balloon for Peripheral Artery Disease sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug Eluting Balloon for Peripheral Artery Disease sales for 2023 through 2029. With Drug Eluting Balloon for Peripheral Artery Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Eluting Balloon for Peripheral Artery Disease industry.

This Insight Report provides a comprehensive analysis of the global Drug Eluting Balloon for Peripheral Artery Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Eluting Balloon for Peripheral Artery Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Drug Eluting Balloon for Peripheral Artery Disease market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Eluting Balloon for Peripheral Artery Disease and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Eluting Balloon for Peripheral Artery Disease.

The global Drug Eluting Balloon for Peripheral Artery Disease market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Drug Eluting Balloon for Peripheral Artery Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Drug Eluting Balloon for Peripheral Artery Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Drug Eluting Balloon for Peripheral Artery Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Drug Eluting Balloon for Peripheral Artery Disease players cover Cook Group, BD, Medtronic, Bayer and Opto Circuits, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Drug Eluting Balloon for Peripheral Artery Disease market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • 3?g/ mm2
  • 2?g/ mm2
  • Others
Segmentation by application
  • Hospitals
  • Ambulatory Surgery Centers
  • Catheterization Laboratories
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Cook Group
  • BD
  • Medtronic
  • Bayer
  • Opto Circuits
Key Questions Addressed in this Report

What is the 10-year outlook for the global Drug Eluting Balloon for Peripheral Artery Disease market?

What factors are driving Drug Eluting Balloon for Peripheral Artery Disease market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Drug Eluting Balloon for Peripheral Artery Disease market opportunities vary by end market size?

How does Drug Eluting Balloon for Peripheral Artery Disease break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Drug Eluting Balloon for Peripheral Artery Disease by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Drug Eluting Balloon for Peripheral Artery Disease by Country/Region, 2018, 2022 & 2029
2.2 Drug Eluting Balloon for Peripheral Artery Disease Segment by Type
  2.2.1 3?g/ mm2
  2.2.2 2?g/ mm2
  2.2.3 Others
2.3 Drug Eluting Balloon for Peripheral Artery Disease Sales by Type
  2.3.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2018-2023)
  2.3.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Type (2018-2023)
2.4 Drug Eluting Balloon for Peripheral Artery Disease Segment by Application
  2.4.1 Hospitals
  2.4.2 Ambulatory Surgery Centers
  2.4.3 Catheterization Laboratories
  2.4.4 Others
2.5 Drug Eluting Balloon for Peripheral Artery Disease Sales by Application
  2.5.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sale Market Share by Application (2018-2023)
  2.5.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Application (2018-2023)

3 GLOBAL DRUG ELUTING BALLOON FOR PERIPHERAL ARTERY DISEASE BY COMPANY

3.1 Global Drug Eluting Balloon for Peripheral Artery Disease Breakdown Data by Company
  3.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Sales by Company (2018-2023)
  3.1.2 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company (2018-2023)
3.2 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Revenue by Company (2018-2023)
  3.2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Company (2018-2023)
  3.2.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Company (2018-2023)
3.3 Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Company
3.4 Key Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Product Location Distribution
  3.4.2 Players Drug Eluting Balloon for Peripheral Artery Disease Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR DRUG ELUTING BALLOON FOR PERIPHERAL ARTERY DISEASE BY GEOGRAPHIC REGION

4.1 World Historic Drug Eluting Balloon for Peripheral Artery Disease Market Size by Geographic Region (2018-2023)
  4.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Drug Eluting Balloon for Peripheral Artery Disease Market Size by Country/Region (2018-2023)
  4.2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Revenue by Country/Region (2018-2023)
4.3 Americas Drug Eluting Balloon for Peripheral Artery Disease Sales Growth
4.4 APAC Drug Eluting Balloon for Peripheral Artery Disease Sales Growth
4.5 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Growth
4.6 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales Growth

5 AMERICAS

5.1 Americas Drug Eluting Balloon for Peripheral Artery Disease Sales by Country
  5.1.1 Americas Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2018-2023)
  5.1.2 Americas Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2018-2023)
5.2 Americas Drug Eluting Balloon for Peripheral Artery Disease Sales by Type
5.3 Americas Drug Eluting Balloon for Peripheral Artery Disease Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Drug Eluting Balloon for Peripheral Artery Disease Sales by Region
  6.1.1 APAC Drug Eluting Balloon for Peripheral Artery Disease Sales by Region (2018-2023)
  6.1.2 APAC Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region (2018-2023)
6.2 APAC Drug Eluting Balloon for Peripheral Artery Disease Sales by Type
6.3 APAC Drug Eluting Balloon for Peripheral Artery Disease Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Drug Eluting Balloon for Peripheral Artery Disease by Country
  7.1.1 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2018-2023)
  7.1.2 Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2018-2023)
7.2 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Type
7.3 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease by Country
  8.1.1 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2018-2023)
8.2 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Type
8.3 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug Eluting Balloon for Peripheral Artery Disease
10.3 Manufacturing Process Analysis of Drug Eluting Balloon for Peripheral Artery Disease
10.4 Industry Chain Structure of Drug Eluting Balloon for Peripheral Artery Disease

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Drug Eluting Balloon for Peripheral Artery Disease Distributors
11.3 Drug Eluting Balloon for Peripheral Artery Disease Customer

12 WORLD FORECAST REVIEW FOR DRUG ELUTING BALLOON FOR PERIPHERAL ARTERY DISEASE BY GEOGRAPHIC REGION

12.1 Global Drug Eluting Balloon for Peripheral Artery Disease Market Size Forecast by Region
  12.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Forecast by Region (2024-2029)
  12.1.2 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug Eluting Balloon for Peripheral Artery Disease Forecast by Type
12.7 Global Drug Eluting Balloon for Peripheral Artery Disease Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Cook Group
  13.1.1 Cook Group Company Information
  13.1.2 Cook Group Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
  13.1.3 Cook Group Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Cook Group Main Business Overview
  13.1.5 Cook Group Latest Developments
13.2 BD
  13.2.1 BD Company Information
  13.2.2 BD Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
  13.2.3 BD Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 BD Main Business Overview
  13.2.5 BD Latest Developments
13.3 Medtronic
  13.3.1 Medtronic Company Information
  13.3.2 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
  13.3.3 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Medtronic Main Business Overview
  13.3.5 Medtronic Latest Developments
13.4 Bayer
  13.4.1 Bayer Company Information
  13.4.2 Bayer Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
  13.4.3 Bayer Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Bayer Main Business Overview
  13.4.5 Bayer Latest Developments
13.5 Opto Circuits
  13.5.1 Opto Circuits Company Information
  13.5.2 Opto Circuits Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
  13.5.3 Opto Circuits Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Opto Circuits Main Business Overview
  13.5.5 Opto Circuits Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Drug Eluting Balloon for Peripheral Artery Disease Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Drug Eluting Balloon for Peripheral Artery Disease Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 3?g/ mm2
Table 4. Major Players of 2?g/ mm2
Table 5. Major Players of Others
Table 6. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2018-2023) & (K Units)
Table 7. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2018-2023)
Table 8. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Type (2018-2023) & ($ million)
Table 9. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Type (2018-2023)
Table 10. Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2018-2023) & (K Units)
Table 12. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2018-2023)
Table 13. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Application (2018-2023)
Table 14. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Application (2018-2023)
Table 15. Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Application (2018-2023) & (USD/Unit)
Table 16. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Company (2018-2023) & (K Units)
Table 17. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company (2018-2023)
Table 18. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Company (2018-2023)
Table 20. Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Company (2018-2023) & (USD/Unit)
Table 21. Key Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Producing Area Distribution and Sales Area
Table 22. Players Drug Eluting Balloon for Peripheral Artery Disease Products Offered
Table 23. Drug Eluting Balloon for Peripheral Artery Disease Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share Geographic Region (2018-2023)
Table 28. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country/Region (2018-2023)
Table 32. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2018-2023) & (K Units)
Table 35. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country (2018-2023)
Table 36. Americas Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country (2018-2023)
Table 38. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2018-2023) & (K Units)
Table 39. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2018-2023) & (K Units)
Table 40. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales by Region (2018-2023) & (K Units)
Table 41. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Region (2018-2023)
Table 42. APAC Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Region (2018-2023)
Table 44. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2018-2023) & (K Units)
Table 45. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2018-2023) & (K Units)
Table 46. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2018-2023) & (K Units)
Table 47. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country (2018-2023)
Table 48. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country (2018-2023)
Table 50. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2018-2023) & (K Units)
Table 51. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Drug Eluting Balloon for Peripheral Artery Disease
Table 59. Key Market Challenges & Risks of Drug Eluting Balloon for Peripheral Artery Disease
Table 60. Key Industry Trends of Drug Eluting Balloon for Peripheral Artery Disease
Table 61. Drug Eluting Balloon for Peripheral Artery Disease Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Drug Eluting Balloon for Peripheral Artery Disease Distributors List
Table 64. Drug Eluting Balloon for Peripheral Artery Disease Customer List
Table 65. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Drug Eluting Balloon for Peripheral Artery Disease Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Drug Eluting Balloon for Peripheral Artery Disease Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Cook Group Basic Information, Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Base, Sales Area and Its Competitors
Table 80. Cook Group Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
Table 81. Cook Group Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Cook Group Main Business
Table 83. Cook Group Latest Developments
Table 84. BD Basic Information, Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Base, Sales Area and Its Competitors
Table 85. BD Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
Table 86. BD Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. BD Main Business
Table 88. BD Latest Developments
Table 89. Medtronic Basic Information, Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Base, Sales Area and Its Competitors
Table 90. Medtronic Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
Table 91. Medtronic Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Medtronic Main Business
Table 93. Medtronic Latest Developments
Table 94. Bayer Basic Information, Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Base, Sales Area and Its Competitors
Table 95. Bayer Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
Table 96. Bayer Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Bayer Main Business
Table 98. Bayer Latest Developments
Table 99. Opto Circuits Basic Information, Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Base, Sales Area and Its Competitors
Table 100. Opto Circuits Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
Table 101. Opto Circuits Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Opto Circuits Main Business
Table 103. Opto Circuits Latest Developments

LIST OF FIGURES

Figure 1. Picture of Drug Eluting Balloon for Peripheral Artery Disease
Figure 2. Drug Eluting Balloon for Peripheral Artery Disease Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Drug Eluting Balloon for Peripheral Artery Disease Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 3?g/ mm2
Figure 10. Product Picture of 2?g/ mm2
Figure 11. Product Picture of Others
Figure 12. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type in 2022
Figure 13. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Type (2018-2023)
Figure 14. Drug Eluting Balloon for Peripheral Artery Disease Consumed in Hospitals
Figure 15. Global Drug Eluting Balloon for Peripheral Artery Disease Market: Hospitals (2018-2023) & (K Units)
Figure 16. Drug Eluting Balloon for Peripheral Artery Disease Consumed in Ambulatory Surgery Centers
Figure 17. Global Drug Eluting Balloon for Peripheral Artery Disease Market: Ambulatory Surgery Centers (2018-2023) & (K Units)
Figure 18. Drug Eluting Balloon for Peripheral Artery Disease Consumed in Catheterization Laboratories
Figure 19. Global Drug Eluting Balloon for Peripheral Artery Disease Market: Catheterization Laboratories (2018-2023) & (K Units)
Figure 20. Drug Eluting Balloon for Peripheral Artery Disease Consumed in Others
Figure 21. Global Drug Eluting Balloon for Peripheral Artery Disease Market: Others (2018-2023) & (K Units)
Figure 22. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2022)
Figure 23. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Application in 2022
Figure 24. Drug Eluting Balloon for Peripheral Artery Disease Sales Market by Company in 2022 (K Units)
Figure 25. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company in 2022
Figure 26. Drug Eluting Balloon for Peripheral Artery Disease Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Company in 2022
Figure 28. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales 2018-2023 (K Units)
Figure 31. Americas Drug Eluting Balloon for Peripheral Artery Disease Revenue 2018-2023 ($ Millions)
Figure 32. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales 2018-2023 (K Units)
Figure 33. APAC Drug Eluting Balloon for Peripheral Artery Disease Revenue 2018-2023 ($ Millions)
Figure 34. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales 2018-2023 (K Units)
Figure 35. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue 2018-2023 ($ Millions)
Figure 38. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country in 2022
Figure 39. Americas Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country in 2022
Figure 40. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2018-2023)
Figure 41. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2018-2023)
Figure 42. United States Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Region in 2022
Figure 47. APAC Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Regions in 2022
Figure 48. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2018-2023)
Figure 49. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2018-2023)
Figure 50. China Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country in 2022
Figure 58. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country in 2022
Figure 59. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2018-2023)
Figure 60. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2018-2023)
Figure 61. Germany Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2018-2023)
Figure 70. Egypt Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Drug Eluting Balloon for Peripheral Artery Disease in 2022
Figure 76. Manufacturing Process Analysis of Drug Eluting Balloon for Peripheral Artery Disease
Figure 77. Industry Chain Structure of Drug Eluting Balloon for Peripheral Artery Disease
Figure 78. Channels of Distribution
Figure 79. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Forecast by Region (2024-2029)
Figure 80. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share Forecast by Application (2024-2029)


More Publications